Publications
The what, why and how of Bayesian clinical trials monitoring.
– Statistics in medicine
(2006)
13,
1371
(doi: 10.1002/sim.4780131312)
Probabilistic prediction in patient management and clinical trials
– Statistics in medicine
(2006)
5,
421
(doi: 10.1002/sim.4780050506)
An analysis of repeated biopsies following cardiac transplantation.
– Statistics in Medicine
(2006)
2,
33
(doi: 10.1002/sim.4780020105)
Evaluation of clinical decision-aids, with an application to a system for dyspepsia.
– Statistics in medicine
(2006)
2,
207
(doi: 10.1002/sim.4780020215)
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion.
– Stat Med
(2006)
5,
1
(doi: 10.1002/sim.4780050103)
Sequential updating of conditional probabilities on directed graphical structures
– Networks
(2006)
20,
579
(doi: 10.1002/net.3230200507)
Screening for diabetic retinopathy: A relative cost‐effectiveness analysis of alternative modalities and strategies
– Health Economics
(2006)
1,
39
(doi: 10.1002/hec.4730010107)
Belief networks and adverse drug reactions: Discussion of papers by G. F. Cooper and D. A. Lane
– Applied Stochastic Models and Data Analysis
(2006)
5,
89
(doi: 10.1002/asm.3150050110)
Flexible random-effects models using Bayesian semi-parametric models: Applications to institutional comparisons
– Statistics in medicine
(2006)
26,
2088
(doi: 10.1002/sim.2666)
What determines the cost-effectiveness of diabetes screening?
– Diabetologia
(2006)
49,
1536
(doi: 10.1007/s00125-006-0248-x)
- <
- 19 of 43